Effect of enoxacin and 4-oxo-enoxacin on antipyrine disposition in the rat
Edwards, D.J.; Waite, N.M.; Svensson, C.K.
Drug Metabolism and Disposition the Biological Fate of Chemicals 16(4): 653-655
1988
ISSN/ISBN: 0090-9556 PMID: 2903039 Document Number: 325230
Document emailed within 1 workday
Related Documents
Katsumi, T.; Murayama, K. 1989: The therapeutic effect of enoxacin on chronic prostatitis Hinyokika Kiyo. Acta Urologica Japonica 35(11): 1985-1987Aquilini, D.; Bartoloni, A.; Paradisi, F. 1991: Effect of enoxacin, norfloxacin and pefloxacin on polymorphonuclear leukocytes chemiluminescence Journal of ChemoTherapy 3(Suppl 1): 116-118
Zhang, Y.Y.; Zhun, B.Y.; Jiang, S.C. 1991: Clinical evaluation of enoxacin Zhonghua Nei Ke Za Zhi 30(8): 480
Mensing, H. 1985: Treatment of chancroid with enoxacin Acta Dermato-Venereologica 65(5): 455-457
McLeod, A.D.; Burgess, C. 1988: Drug interaction between warfarin and enoxacin New Zealand Medical Journal 101(844): 216
Soussy, C.J.; Deforges, L.; Duval, J. 1987: Antibacterial activity of enoxacin in vitro and in urine Pathologie-Biologie 35(5): 475-481
Yasumoto, R.; Asakawa, M. 1988: Enoxacin in the seminal fluid of prostatitis patients Hinyokika Kiyo. Acta Urologica Japonica 34(6): 1101-1103
Spurlock, C.H. 1986: Increasing solubility of enoxacin and norfloxacin by means of salt formation Journal of Parenteral Science and Technology: a Publication of the Parenteral Drug Association 40(2): 70-72
Yasumoto, R.; Asakawa, M. 1988: Comparison of enoxacin, ofloxacin, and norfloxacin concentration in human benign prostatic tissue Hinyokika Kiyo. Acta Urologica Japonica 34(8): 1519-1521
Kamei, C.; Sugimoto, Y.; Ohishi, H.; Okumura, Y.; Kitazumi, K. 1996: Epileptogenic activity induced by combined treatment with antiinflammatory drugs and enoxacin and its inhibition by a calcium antagonist, nicardipine Methods and Findings in Experimental and Clinical Pharmacology 18(9): 579-588
Vree, T.B.; Baars, A.M.; Wijnands, W.J. 1985: High-performance liquid chromatography and preliminary pharmacokinetics of enoxacin and its 4-oxo metabolite in human plasma, urine and saliva Journal of Chromatography 343(2): 449-454
Debruyne, D.; Gram, L.F.; Grollier, G.; Camsonne, R.; Agron, L.; Dao, M.T.; Lacotte, J.; Bigot, M.C.; Moulin, M. 1989: Quinidine disposition in relation to antipyrine elimination and debrisoquine phenotype in alcoholic patients with and without cirrhosis International Journal of Clinical Pharmacology Research 9(5): 319-325
Tse, F.L.; Chang, T.; Jaffe, J.M. 1986: Effect of butalbital and phenobarbital pretreatment on antipyrine clearance in the rat Archives Internationales de Pharmacodynamie et de Therapie 279(2): 181-194
Tsagareĭshvili, K.A.; Omel'chenko, O.G. 1987: Effect of alcohol on the rate of antipyrine biotransformation in the guinea pig Vestnik Dermatologii i Venerologii 1: 63-66
Kövamees, A. 1970: Skin and muscle celarance with 133-xenon and 125-iodine antipyrine. Effect of vascular reconstruction examined Journal of Cardiovascular Surgery 11(6): 479-481
Gaevyi, M.D. 1971: Effect of amidopyrine, antipyrine, analgine and sodium salicylate on the tonus of intracranial and extracranial vessels Farmakologiia i Toksikologiia 34(2): 174-181
Farmer, T.W.; DeAngelis, R.L.; Welch, R.M. 1975: Effect of anticonvulsant drugs on the drug metabolism in man as measured by the elimination rate of antipyrine from saliva Transactions of the American Neurological Association 100: 190-191
Hayes, P.C.; Bouchier, I.A. 1989: Effect of acute and chronic propranolol administration on antipyrine and paracetamol clearance in patients with chronic liver disease American Journal of Gastroenterology 84(7): 723-726
D'Mello, A.P.; Venkataramanan, R.V.; Bates, T.R. 1992: Effect of miconazole on warfarin disposition in rabbits Drug Metabolism and Disposition: the Biological Fate of Chemicals 20(4): 572-577
Swanson, B.N.; Mojaverian, P.; Boppana, V.K.; Dudash, M.R. 1981: Effect of dimethyl sulfoxide on sulindac disposition in rats Drug Metabolism and Disposition: the Biological Fate of Chemicals 9(6): 499-502